Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0122699386503067 0.0355828220858897 0.0355828220858897 0.0355828220858897
Stock impact report

Beam Therapeutics to Present First Data Highlighting Base Editing Program for Alpha-1 Antitrypsin Deficiency at 23rd ASGCT Annual Meeting

Beam Therapeutics Inc. (BEAM) 
Company Research Source: GlobeNewswire
CAMBRIDGE, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced preclinical data showcasing the potential of its novel base editing approach for the treatment of alpha-1 antitrypsin deficiency (Alpha-1) liver and lung diseases. The data will be presented in oral and poster sessions during the 23rd American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, which will be hosted virtually May 12-15, 2020. In addition, Beam will highlight data from its Alpha-1 program in a pre-meeting workshop presentation on Monday, May 11, 2020 from 3:50 p.m. – 4:10 p.m. ET. Alpha-1 is a rare, inherited genetic disorder that can cause progressive lung and liver disease. It is most commonly caused by a G-to-A point mutation – referred to as the PiZ allele – within the SERPINA1 gene, which produces alpha-1 antitrypsin (A1AT) protein. In healthy individuals, the A1AT pr Show less Read more
Impact Snapshot
Event Time:
BEAM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
BEAM alerts

from News Quantified
Opt-in for
BEAM alerts

from News Quantified